Saw palmetto (Serenoa repens) extract is the most widely used natural supplement for prostate health in Europe and North America. It has been used medicinally by Native American peoples for centuries and has attracted substantial clinical investigation for benign prostatic hyperplasia (BPH) — the non-cancerous enlargement of the prostate gland that causes urinary symptoms in many men over 50. The evidence story, however, is complicated by a large, definitive NIH-funded trial that found no benefit.
Benign prostatic hyperplasia affects approximately 50% of men by age 50 and up to 90% of men by their eighties. The enlarged prostate gland compresses the urethra, causing lower urinary tract symptoms (LUTS) including frequent urination, urgency, weak urine stream, incomplete bladder emptying, and nocturia (waking at night to urinate). While BPH is not cancerous, these symptoms significantly affect quality of life.
In Ireland, BPH management is typically handled initially in general practice, with alpha-1 blockers (tamsulosin) and 5-alpha reductase inhibitors (finasteride) as standard first-line medications. The economic and quality-of-life burden is substantial, driving strong interest in complementary approaches.
Saw palmetto berry extract contains free fatty acids, phytosterols (particularly beta-sitosterol), and fatty acid esters. The primary proposed mechanism is inhibition of 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT) — the androgen primarily responsible for prostate gland growth. Finasteride (Proscar), the pharmaceutical BPH medication, works by the same mechanism. However, saw palmetto's inhibition of 5-alpha reductase is considerably weaker than finasteride in direct comparison studies.
Early positive evidence: Multiple European trials from the 1980s and 1990s produced positive results. A 1998 meta-analysis by Wilt et al. (JAMA) pooling 18 trials (n=2,939 men) found saw palmetto improved urinary symptom scores and peak urinary flow rate compared to placebo and was comparable to finasteride for symptom relief with fewer side effects (particularly fewer sexual side effects). This was the basis for widespread adoption.
The STEP trial: The NIH-funded STEP (Saw Palmetto for Treatment of Enlarged Prostates) trial (Bent et al. 2006, NEJM, n=225) was a well-designed, double-blind RCT using 320 mg/day of saw palmetto extract over 12 months. It found no difference in American Urological Association Symptom Score, maximum urinary flow rate, prostate size, quality of life scores, or PSA levels between saw palmetto and placebo. This was a high-quality, adequately powered, definitive trial.
CAMUS trial (2011): The subsequent CAMUS trial (Barry et al. 2011, JAMA, n=369) used escalating doses of saw palmetto up to 960 mg/day (three times the standard dose) over 72 weeks — also finding no benefit over placebo at any dose.
These two large, well-conducted NIH-funded trials substantially undermined the earlier positive evidence. The discrepancy between early European positive trials and later high-quality North American negative trials is possibly explained by methodological weaknesses in the earlier trials and/or differences in product quality and standardisation.
| Claim | Evidence Level | Source |
|---|---|---|
| Saw palmetto improves BPH urinary symptoms | Limited / Conflicted | Early meta-analysis positive (Wilt 1998); STEP and CAMUS trials negative |
| Saw palmetto comparable to finasteride for BPH | Limited | Based on earlier lower-quality trials; superseded by high-quality negative RCTs |
| Saw palmetto inhibits 5-alpha reductase | Moderate (pharmacological) | In vitro studies; weaker effect than finasteride |
| Saw palmetto does not affect PSA levels | Moderate | Multiple trials show no PSA suppression — important for prostate cancer screening |
| Saw palmetto prevents prostate cancer | Limited | No clinical trial evidence |
Despite the large negative trials, saw palmetto remains popular because:
Unlike finasteride and dutasteride, saw palmetto does not appear to meaningfully suppress PSA (prostate-specific antigen) levels. This is actually important — finasteride lowers PSA as a side effect, which can complicate prostate cancer screening. Saw palmetto does not create this confound.
However, urinary symptoms that could be BPH should always be evaluated by a GP first, as prostate cancer can cause similar symptoms. Do not self-treat prostate symptoms without a proper medical assessment and PSA measurement.
Generally well tolerated: Saw palmetto has a good tolerability profile. The most common side effects are mild GI upset. Unlike finasteride, it is not associated with significant sexual dysfunction in the trial data.
Anticoagulants: Saw palmetto may have mild antiplatelet effects. A small number of cases of increased bleeding time have been reported. People on warfarin, aspirin, or other anticoagulants should discuss with their pharmacist before use.
Hormonal medications: Saw palmetto may theoretically interact with hormonal medications and contraceptives due to its weak anti-androgenic and possible oestrogenic activity. Discuss with your GP if taking hormone-based medications.
PSA test accuracy: While saw palmetto does not suppress PSA as markedly as finasteride, inform your GP you are taking it before PSA testing.
Prostate cancer: Saw palmetto is not a treatment for prostate cancer and should never be used in place of specialist oncological management.
Saw palmetto has a complicated evidence story. The early positive evidence created a market; the large, well-conducted NIH trials found no benefit. The honest position is that the higher-quality evidence does not support saw palmetto as an effective treatment for BPH urinary symptoms. That said, it has a good safety profile, does not suppress PSA (unlike finasteride), and many men report subjective improvement — possibly through placebo, possibly through mechanisms not yet fully understood. It is a low-risk intervention but one for which the evidence has not held up under rigorous scrutiny. Men with significant BPH symptoms should see their GP for proper assessment and evidence-based management.
For saw palmetto and men's health supplements, shop at our partner
Shop at The Honey Pot →